Atlas Trials

A Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer

Clinical trial NCT01469793 · COMPLETED

Trial details

NCT number
NCT01469793
Sponsor
Genentech, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2011-11-01
Primary completion
2015-12-01
Enrollment
71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.